Search

Your search keyword '"Siersema, P"' showing total 1,476 results
Start Over Author "Siersema, P"
1,476 results on '"Siersema, P"'

1. Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data Meta-Analysis

Author

Sperna Weiland, Christina J., Akshintala, Venkata S., Singh, Anmol, Buxbaum, James, Choi, Jun-Ho, Elmunzer, Badih J., Fogel, Evan S., Lai, Jian-Han, Levenick, John M., Gardner, Timothy B., Lua, Guan W., Luo, Hui, de Jong, Mike, Mok, Shaffer R. S., Phillip, Veit, Singh, Vikesh, Siersema, Peter D., Drenth, Joost P. H., and van Geenen, Erwin J. M.

Published
2024
Full Text
View/download PDF

3. Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial

Author

Kemper, Gijs, Gerges, Christian, Schoon, Erik J., Schreuder, Ramon-Michel, Schrauwen, Ruud R. W., Epping, Ludger S. M., Beyna, Torsten, Drenth, Joost P. H., Gündug, Ufuk, Siersema, Peter D., and van Geenen, Erwin J. M.

Published
2024
Full Text
View/download PDF

4. Dutch, UK and US professionals perceptions of screening for Barretts esophagus and esophageal adenocarcinoma: a concept mapping study.

Author

Sijben, Jasmijn, Rainey, Linda, Peters, Yonne, Fitzgerald, Rebecca, Wani, Sachin, Broeders, Mireille, Siersema, Peter, and Kolb, Jennifer

Subjects
Barrett’s esophagus, Early cancer diagnosis, Esophageal adenocarcinoma, Physician’s practice patterns, Screening, Humans, Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma, United Kingdom
Abstract

BACKGROUND: Novel, less-invasive technologies to screen for Barretts esophagus (BE) may enable a paradigm shift in early detection strategies for esophageal adenocarcinoma (EAC). Understanding professionals perspectives on screening is important to determine how to proceed. We aimed to explore and compare professionals perceptions of screening for BE and EAC screening in three countries. METHODS: In this study, 29 Dutch, 20 British and 18 American health care professionals (clinicians, researchers and policy makers) participated in concept mapping: a mixed-methods consensus building methodology. Statements on perceived barriers, facilitators, advantages, disadvantages, implications or worries associated with screening for BE and EAC were collected in asynchronous digital brainstorm sessions. Subsequently, participants sorted the statements into groups according to thematic similarity and assessed the relevance of each statement in evaluating the acceptability of BE and EAC screening. Multidimensional scaling and cluster analysis were used to map the associations between generated statements. RESULTS: Professionals across three countries identified eight consistent themes that relate to their perceptions of screening for BE and EAC: (1) Benefits, (2) Harms, (3) Clinical effectiveness concerns, (4) Screening population, (5) Screening modality, (6) Resources, (7) Ownership, and (8) Public communication. Dutch and American professionals prioritized the potential health benefits of screening but also questioned clinical impact. In contrast, British participants prioritized identification of the screening population and suitable test. CONCLUSIONS: Most professionals see potential in less-invasive screening tests for BE and EAC but underline the need to define the target screening population and determine benefits and harms before widely employing them. Successful implementation will require thoughtful consideration of the involvement of general practitioners, readiness of endoscopy and pathology services, balanced public communication, and country-specific regulations.

Published
2023

5. Impact of 18FFDG-PET/CT and Laparoscopy in Staging of Locally Advanced Gastric Cancer: A Cost Analysis in the Prospective Multicenter PLASTIC-Study

Author

de Jongh, Cas, van der Meulen, Miriam P., Gertsen, Emma C., Brenkman, Hylke J. F., van Sandick, Johanna W., van Berge Henegouwen, Mark I., Gisbertz, Suzanne S., Luyer, Misha D. P., Nieuwenhuijzen, Grard A. P., van Lanschot, Jan J. B., Lagarde, Sjoerd M., Wijnhoven, Bas P. L., de Steur, Wobbe O., Hartgrink, Henk H., Stoot, Jan H. M. B., Hulsewe, Karel W. E., Spillenaar Bilgen, Ernst Jan, van Det, Marc J., Kouwenhoven, Ewout A., Daams, Freek, van der Peet, Donald L., van Grieken, Nicole C. T., Heisterkamp, Joos, van Etten, Boudewijn, van den Berg, Jan-Willem, Pierie, Jean-Pierre, Eker, Hasan H., Thijssen, Annemieke Y., Belt, Eric J. T., van Duijvendijk, Peter, Wassenaar, Eelco, Wevers, Kevin P., Hol, Lieke, Wessels, Frank J., Haj Mohammad, Nadia, Frederix, Geert W. J., van Hillegersberg, Richard, Siersema, Peter D., Vegt, Erik, and Ruurda, Jelle P.

Published
2024
Full Text
View/download PDF

8. ASO Visual Abstract: Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study

Author

Gertsen, Emma C., van der Veen, Arjen, Brenkman, Hylke J. F., Brosens, Lodewijk A. A., van der Post, Rachel S., Verhoeven, Rob H. A., Luijten, Josianne C. H. B. M., Vissers, Pauline A. J., Vegt, Erik, van Hillegersberg, Richard, Siersema, Peter D., and Ruurda, Jelle P.

Published
2024
Full Text
View/download PDF

12. EAES rapid guideline: updated systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed European recommendations on the management of common bile duct stones

Author

Boni, Luigi, Huo, Bright, Alberici, Laura, Ricci, Claudio, Tsokani, Sofia, Mavridis, Dimitris, Amer, Yasser Sami, Andreou, Alexandros, Berriman, Thomas, Donatelli, Gianfranco, Forbes, Nauzer, Kapiris, Stylianos, Kayaalp, Cüneyt, Kylänpää, Leena, Parra-Membrives, Pablo, Siersema, Peter D., Black, George F., and Antoniou, Stavros A.

Published
2022
Full Text
View/download PDF

17. Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations

Author

Nimptsch, Katharina, Aleksandrova, Krasimira, Fedirko, Veronika, Jenab, Mazda, Gunter, Marc J., Siersema, Peter D., Wu, Kana, Katzke, Verena, Kaaks, Rudolf, Panico, Salvatore, Palli, Domenico, May, Anne M, Sieri, Sabina, Bueno-de-Mesquita, Bas, Standahl, Karina, Sánchez, Maria-Jose, Perez-Cornago, Aurora, Olsen, Anja, Tjønneland, Anne, Bonet, Catalina Bonet, Dahm, Christina C., Chirlaque, María-Dolores, Fiano, Valentina, Tumino, Rosario, Gurrea, Aurelio Barricarte, Boutron-Ruault, Marie-Christine, Menegaux, Florence, Severi, Gianluca, van Guelpen, Bethany, Lee, Young-Ae, and Pischon, Tobias

Published
2022
Full Text
View/download PDF

20. Oesofaguscarcinoom

Author

Wijnhoven, B. P. L., Haustermans, K., Siersema, P. D., van Laarhoven, H. W. M., van Sandick, J. W., van Krieken, J.H.J.M., editor, Beets-Tan, R.G.H., editor, Gelderblom, A.J., editor, Olofsen, M.J.J., editor, and Rutten, H.J.T., editor

Published
2020
Full Text
View/download PDF

22. The Gastroscopy RAte of Cleanliness Evaluation (GRACE) Scale: time to establish a Grading Scale for Upper Gastrointestinal Endoscopy

Author

Esposito, G., additional, Ligato, I., additional, Dilaghi, E., additional, Libanio, D., additional, Chaves, J., additional, Arantes, V. N., additional, Moresi, R., additional, Weusten, B., additional, Bac, S., additional, Elvas, L., additional, Viegas, M. I., additional, Bergman, J., additional, Boonstra, K., additional, Bisschops, R., additional, Sinonquel, P., additional, Andrisani, G., additional, Di Matteo, F. M., additional, Citterio, N., additional, Ebigbo, A., additional, Ayoub, M., additional, Ferlitsch, M., additional, Frick, A., additional, Giljaca, V., additional, Tahir, I., additional, Hassan, C., additional, Capogreco, A., additional, Dal Buono, A., additional, Hucl, T., additional, Macinga, P., additional, De Jonge, P. J., additional, Van De Ven, S. E., additional, Kuvaev, R., additional, Filimendikova, K., additional, Leclercq, P., additional, Plomteux, O., additional, Angeletti, S., additional, Dell'unto, E., additional, Le Rhun, M., additional, Prouvost, V., additional, Yuichi, M., additional, Halvorsen, N., additional, Moss, A., additional, Nicolaides, S., additional, Perez-Cuadrado-Robles, E., additional, Gonzalez, E. Tenorio, additional, Pouw, R., additional, Meijer, B., additional, Rex, D. K., additional, Guardiola, J., additional, De Santiago, E. Rodriguez, additional, Chivato, I., additional, Siersema, P. D., additional, Borren, N., additional, Tham, T. C., additional, Tang, K., additional, Triantafyllou, K., additional, Samarentzis, N., additional, Voiosu, A. M., additional, Dragan, V., additional, Dinis-Ribeiro, M., additional, and Areia, M., additional

Published
2024
Full Text
View/download PDF

23. Impact of EUS-guided choledochoduodenostomy versus transpapillary endoscopic biliary drainage on the intra- and post-operative outcome of pancreatoduodenectomy: a multicenter propensity score matched study

Author

Fritzsche, J. A., additional, De Jong, M. J., additional, Bonsing, B. A., additional, Busch, O., additional, Daams, F., additional, Van Delft, F., additional, Derksen, W. J., additional, Erdmann, J. I., additional, Festen, S., additional, Fockens, P., additional, Van Geenen, E. M., additional, Inderson, A., additional, Kazemier, G., additional, Kuiken, S. D., additional, Liem, M. S., additional, Lips, D. J., additional, Te Riele, W., additional, Van Santvoort, H., additional, Siersema, P. D., additional, Venneman, N. G., additional, Verdonk, R., additional, Vleggaar, F., additional, Besselink, M., additional, van Wanrooij, R.L J, additional, and Voermans, R. P., additional

Published
2024
Full Text
View/download PDF

24. Comparison of abdominal adiposity and overall obesity in relation to risk of small intestinal cancer in a European Prospective Cohort

Author

Lu, Yunxia, Cross, Amanda J, Murphy, Neil, Freisling, Heinz, Travis, Ruth C, Ferrari, Pietro, Katzke, Verena A, Kaaks, Rudolf, Olsson, Åsa, Johansson, Ingegerd, Renström, Frida, Panico, Salvatore, Pala, Valeria, Palli, Domenico, Tumino, Rosario, Peeters, Petra H, Siersema, Peter D, Bueno-de-Mesquita, HB, Trichopoulou, Antonia, Klinaki, Eleni, Tsironis, Christos, Agudo, Antonio, Navarro, Carmen, Sánchez, María-José, Barricarte, Aurelio, Boutron-Ruault, Marie-Christine, Fagherazzi, Guy, Racine, Antoine, Weiderpass, Elisabete, Gunter, Marc J, and Riboli, Elio

Subjects
Biomedical and Clinical Sciences, Epidemiology, Public Health, Health Sciences, Nutrition and Dietetics, Obesity, Prevention, Nutrition, Cancer, Digestive Diseases, 2.1 Biological and endogenous factors, Aetiology, Oral and gastrointestinal, Cardiovascular, Stroke, Adenocarcinoma, Adiposity, Adult, Aged, Body Height, Body Mass Index, Europe, Female, Humans, Intestinal Neoplasms, Male, Middle Aged, Proportional Hazards Models, Prospective Studies, Risk Factors, Waist Circumference, Waist-Hip Ratio, White People, Abdominal obesity, Small intestine, Oncology and Carcinogenesis, Public Health and Health Services, Oncology and carcinogenesis
Abstract

BackgroundThe etiology of small intestinal cancer (SIC) is largely unknown, and there are very few epidemiological studies published to date. No studies have investigated abdominal adiposity in relation to SIC.MethodsWe investigated overall obesity and abdominal adiposity in relation to SIC in the European Prospective Investigation into Cancer and Nutrition (EPIC), a large prospective cohort of approximately half a million men and women from ten European countries. Overall obesity and abdominal obesity were assessed by body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR). Multivariate Cox proportional hazards regression modeling was performed to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs). Stratified analyses were conducted by sex, BMI, and smoking status.ResultsDuring an average of 13.9 years of follow-up, 131 incident cases of SIC (including 41 adenocarcinomas, 44 malignant carcinoid tumors, 15 sarcomas and 10 lymphomas, and 21 unknown histology) were identified. WC was positively associated with SIC in a crude model that also included BMI (HR per 5-cm increase = 1.20, 95 % CI 1.04, 1.39), but this association attenuated in the multivariable model (HR 1.18, 95 % CI 0.98, 1.42). However, the association between WC and SIC was strengthened when the analysis was restricted to adenocarcinoma of the small intestine (multivariable HR adjusted for BMI = 1.56, 95 % CI 1.11, 2.17). There were no other significant associations.ConclusionWC, rather than BMI, may be positively associated with adenocarcinomas but not carcinoid tumors of the small intestine.ImpactAbdominal obesity is a potential risk factor for adenocarcinoma in the small intestine.

Published
2016

26. Body iron status and gastric cancer risk in the EURGAST study

Author

Fonseca-Nunes, Ana, Agudo, Antonio, Aranda, Núria, Arija, Victoria, Cross, Amanda J, Molina, Esther, Sanchez, Maria Jose, Bueno-de-Mesquita, HB As, Siersema, Peter, Weiderpass, Elisabete, Krogh, Vittorio, Mattiello, Amalia, Tumino, Rosario, Saieva, Calogero, Naccarati, Alessio, Ohlsson, Bodil, Sjöberg, Klas, Boutron-Ruault, Marie-Christine, Cadeau, Claire, Fagherazzi, Guy, Boeing, Heiner, Steffen, Annika, Kühn, Tilman, Katzke, Verena, Tjønneland, Anne, Olsen, Anja, Khaw, Kay-Tee, Wareham, Nick, Key, Tim, Lu, Yunxia, Riboli, Elio, Peeters, Petra H, Gavrila, Diana, Dorronsoro, Miren, Quirós, José Ramón, Barricarte, Aurelio, Jenab, Mazda, Zamora-Ros, Raúl, Freisling, Heinz, Trichopoulou, Antonia, Lagiou, Pagona, Bamia, Christina, and Jakszyn, Paula

Subjects
Biomedical and Clinical Sciences, Nutrition and Dietetics, Oncology and Carcinogenesis, Clinical Research, Digestive Diseases, Nutrition, Rare Diseases, Prevention, Cancer, 2.1 Biological and endogenous factors, Aetiology, Adenocarcinoma, Case-Control Studies, Ferritins, Humans, Iron, Risk Factors, Stomach Neoplasms, gastric cancer, iron homeostasis, nested case-control study, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

Although it appears biologically plausible for iron to be associated with gastric carcinogenesis, the evidence is insufficient to lead to any conclusions. To further investigate the relationship between body iron status and gastric cancer risk, we conducted a nested case-control study in the multicentric European Prospective Investigation into Cancer and Nutrition (EPIC) study. The study included 456 primary incident gastric adenocarcinoma cases and 900 matched controls that occurred during an average of 11 years of follow-up. We measured prediagnostic serum iron, ferritin, transferrin and C-reactive protein, and further estimated total iron-binding capacity (TIBC) and transferrin saturation (TS). Odds ratios (ORs) and 95% confidence intervals (CIs) for the risk of gastric cancer by iron metrics were estimated from multivariable conditional logistic regression models. After adjusting for relevant confounders, we observed a statistically significant inverse association between gastric cancer and ferritin and TS indices (ORlog2  = 0.80, 95% CI = 0.72-0.88; OR10%increment  = 0.87, 95% CI = 0.78-0.97, respectively). These associations appear to be restricted to noncardia gastric cancer (ferritin showed a p for heterogeneity = 0.04 and TS had a p for heterogeneity = 0.02), and no differences were found by histological type. TIBC increased risk of overall gastric cancer (OR50 µg/dl  = 1.13, 95% CI = 1.02-1.2) and also with noncardia gastric cancer (p for heterogeneity = 0.04). Additional analysis suggests that time between blood draw and gastric cancer diagnosis could modify these findings. In conclusion, our results showed a decreased risk of gastric cancer related to higher body iron stores as measured by serum iron and ferritin. Further investigation is needed to clarify the role of iron in gastric carcinogenesis.

Published
2015

27. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition

Author

Steffen, Annika, Huerta, José-Maria, Weiderpass, Elisabete, Bueno-de-Mesquita, HB As, May, Anne M, Siersema, Peter D, Kaaks, Rudolf, Neamat-Allah, Jasmine, Pala, Valeria, Panico, Salvatore, Saieva, Calogero, Tumino, Rosario, Naccarati, Alessio, Dorronsoro, Miren, Sánchez-Cantalejo, Emilio, Ardanaz, Eva, Quirós, J Ramón, Ohlsson, Bodil, Johansson, Mattias, Wallner, Bengt, Overvad, Kim, Halkjaer, Jytte, Tjønneland, Anne, Fagherazzi, Guy, Racine, Antoine, Clavel-Chapelon, Françoise, Key, Tim J, Khaw, Kay-Tee, Wareham, Nick, Lagiou, Pagona, Bamia, Christina, Trichopoulou, Antonia, Ferrari, Pietro, Freisling, Heinz, Lu, Yunxia, Riboli, Elio, Cross, Amanda J, Gonzalez, Carlos A, and Boeing, Heiner

Subjects
Biomedical and Clinical Sciences, Nutrition and Dietetics, Prevention, Rare Diseases, Digestive Diseases, Cancer, Obesity, Nutrition, Adenocarcinoma, Adult, Aged, Body Mass Index, Body Weights and Measures, Esophageal Neoplasms, Europe, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Abdominal, Population Surveillance, Prospective Studies, Risk, Risk Factors, Stomach Neoplasms, abdominal obesity, body mass index, esophageal cancer, gastric cancer, general obesity, waist circumference, Oncology and Carcinogenesis, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

General obesity, as reflected by BMI, is an established risk factor for esophageal adenocarcinoma (EAC), a suspected risk factor for gastric cardia adenocarcinoma (GCC) and appears unrelated to gastric non-cardia adenocarcinoma (GNCC). How abdominal obesity, as commonly measured by waist circumference (WC), relates to these cancers remains largely unexplored. Using measured anthropometric data from 391,456 individuals from the European Prospective Investigation into Cancer and Nutrition (EPIC) study and 11 years of follow-up, we comprehensively assessed the association of anthropometric measures with risk of EAC, GCC and GNCC using multivariable proportional hazards regression. One hundred twenty-four incident EAC, 193 GCC and 224 GNCC were accrued. After mutual adjustment, BMI was unrelated to EAC, while WC showed a strong positive association (highest vs. lowest quintile HR = 1.19; 95% CI, 0.63-2.22 and HR = 3.76; 1.72-8.22, respectively). Hip circumference (HC) was inversely related to EAC after controlling for WC, while WC remained positively associated (HR = 0.35; 0.18-0.68, and HR=4.10; 1.94-8.63, respectively). BMI was not associated with GCC or GNCC. WC was related to higher risks of GCC after adjustment for BMI and more strongly after adjustment for HC (highest vs. lowest quintile HR = 1.91; 1.09-3.37, and HR = 2.23; 1.28-3.90, respectively). Our study demonstrates that abdominal, rather than general, obesity is an indisputable risk factor for EAC and also provides evidence for a protective effect of gluteofemoral (subcutaneous) adipose tissue in EAC. Our study further shows that general obesity is not a risk factor for GCC and GNCC, while the role of abdominal obesity in GCC needs further investigation.

Published
2015

30. Oesofaguscarcinoom

Author

Wijnhoven, B. P. L., Haustermans, K., Siersema, P. D., van de Velde, C.J.H., editor, van der Graaf, W.T.A., editor, van Krieken, J.H.J.M., editor, and Marijnen, C.A.M., editor

Published
2017
Full Text
View/download PDF

31. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease

Author

Lutgens, MWMD, Oldenburg, B, Siersema, PD, van Bodegraven, AA, Dijkstra, G, Hommes, DW, de Jong, DJ, Stokkers, PCF, van der Woude, CJ, Vleggaar, FP, and On behalf of the Initiative on Crohn and Colitis (ICC)

Subjects
Digestive Diseases, Autoimmune Disease, Colo-Rectal Cancer, Cancer, Inflammatory Bowel Disease, Adult, Aged, Aged, 80 and over, Colonoscopy, Colorectal Neoplasms, Female, Humans, Inflammatory Bowel Diseases, Male, Middle Aged, Neoplasm Staging, Regression Analysis, Survival Rate, Tomography, X-Ray Computed, Young Adult, inflammatory bowel disease, colorectal cancer, surveillance, survival, tumour stage, IBD, CRC, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis
Abstract

BackgroundColonoscopic surveillance provides the best practical means for preventing colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients. Strong evidence for improved survival from surveillance programmes is sparse.MethodThe aim of this study was to compare tumour stage and survival of IBD patients with CRC who were a part of a surveillance programme with those who were not. A nationwide pathology database (PALGA (pathologisch anatomisch landelijk geautomatiseerd archief)) was consulted to identify IBD patients with CRC treated in all eight university hospitals in The Netherlands over a period of 15 years. Patients were assigned to the surveillance group when they had undergone one or more surveillance colonoscopies before a diagnosis of CRC. Patients who had not undergone surveillance served as controls. Tumour stage and survival were compared between the two groups.ResultsA total of 149 patients with IBD-associated CRC were identified. Twenty-three had had colonoscopic surveillance before CRC was discovered. The 5-year CRC-related survival rate of patients in the surveillance group was 100% compared with 74% in the non-surveillance group (P=0.042). In the surveillance group, only one patient died as a consequence of CRC compared with 29 patients in the control group (P=0.047). In addition, more early tumour stages were found in the surveillance group (P=0.004).ConclusionsThese results provide evidence for improved survival from colonoscopic surveillance in IBD patients by detecting CRC at a more favourable tumour stage.

Published
2009

36. A computer-aided polyp detection system in screening and surveillance colonoscopy: an international, multicentre, randomised, tandem trial

Author

Maas, Michiel H J, Neumann, Helmut, Shirin, Haim, Katz, Lior H, Benson, Ariel A, Kahloon, Arslan, Soons, Elsa, Hazzan, Rawi, Landsman, Marc J, Lebwohl, Benjamin, Lewis, Suzanne K, Sivanathan, Visvakanth, Ngamruengphong, Saowanee, Jacob, Harold, and Siersema, Peter D

Abstract

Studies on the effect of computer-aided detection (CAD) in a daily clinical screening and surveillance colonoscopy population practice are scarce. The aim of this study was to evaluate a novel CAD system in a screening and surveillance colonoscopy population.

Published
2024
Full Text
View/download PDF

37. An intraprocedural bowel cleansing system for difficult‐to‐prepare patients—A multicenter prospective feasibility study

Author

Riswijk, Milou L. M., Keulen, Kelly E., Neumann, Helmut, and Siersema, Peter D.

Abstract

Adequate bowel preparation is a prerequisite for colonoscopy. However, up to 20% of colonoscopies remain inadequately prepared. Risk factors for inadequate bowel preparation often overlap with those of failed cecal intubation. This study aimed to assess the feasibility of an intraprocedural bowel cleansing system (BCS) in patients with a history of inadequate bowel preparation. Patients (n= 44) with a history of inadequate bowel preparation in the past 2 years were included. After a limited preparation with 300 mL split‐dose sodium picosulfate magnesium citrate, additional cleansing during colonoscopy was performed with the BCS. The primary outcome was adequate bowel preparation using the Boston Bowel Preparation Scale (BBPS). Secondary outcomes included cecal intubation rate, procedure times, usability, and safety. Median BBPS increased from 1‐2‐2 (IQR 1–2) to 3‐3‐3 (IQR) (p< 0.0001), with 31.8% and 88.6% of patients adequately prepared before and after using the BCS, respectively (p< 0.0001). Cecal intubation rate was 88.6%. Reasons for incomplete colonoscopy were looping (n= 2), technical failure (n= 1), relative stricture (n= 1), and residual feces (n= 1). In patients with complete colonoscopy, the adequate cleansing rate was 97.5%. Median total procedure time was 26 min, of which 5.3 min were spent on cleaning. General ease of use was scored with a median of 4 out of 5, representing “as good as conventional colonoscopy”. No serious adverse events occurred. Adequate bowel cleaning can be achieved with an intraprocedural BCS in patients with a history of inadequate bowel preparation, which may reduce repeat colonoscopies and clinical admissions for bowel preparation. However, since these patients more frequently have complicated anatomy (surgical scarring, diverticulosis, etc.), adequate patient selection is advised to avoid incomplete procedures.

Published
2024
Full Text
View/download PDF

38. Barrett oesophagus

Author

Peters, Yonne, Al-Kaabi, Ali, Shaheen, Nicholas J., Chak, Amitabh, Blum, Andrew, Souza, Rhonda F., Di Pietro, Massimiliano, Iyer, Prasad G., Pech, Oliver, Fitzgerald, Rebecca C., and Siersema, Peter D.

Published
2019
Full Text
View/download PDF

40. Standardizing training for endoscopic mucosal resection of large non-pedunculated colorectal polyps to reduce recurrence (*STAR-LNPCP study): a multicenter, cluster randomized trial

Author

Meulen, L.W. T., additional, Bogie, R.M. M., additional, Siersema, P. D., additional, Winkens, B., additional, Vlug, M., additional, Wolfhagen, F., additional, Baven-Pronk, M., additional, Van Der Voorn, M., additional, Schwartz, M. P., additional, Vogelaar, L., additional, De Vos Tot Nederveen Cappel, W. H., additional, Seerden, T., additional, Hazen, W. L., additional, Schrauwen, R.W. M., additional, Herrero, L. Alvarez, additional, Schreuder, R. M., additional, Van Nunen, A. B., additional, Stoop, E., additional, De Bruin, G. J., additional, Bos, P., additional, Marsman, W. A., additional, Kuiper, E., additional, De Bièvre, M., additional, Alderlieste, Y., additional, Roomer, R., additional, Groen, J. N., additional, Bigirwamungu-Bargeman, M., additional, Van Leerdam, M., additional, Roberts-Bos, L., additional, Boersma, F., additional, Thurnau, K., additional, De Vries, R. S., additional, Ramaker, J. M., additional, De Ridder, R.J. J., additional, Pellisé, M., additional, Bourke, M. J., additional, Masclee, A.A. M., additional, and Moons, L.M. G., additional

Published
2023
Full Text
View/download PDF

42. A novel computer-aided polyp detection system in daily clinical care: an international multicenter, randomized, tandem trial

Author

Maas, M., additional, Neumann, H., additional, Shirin, H., additional, Katz, L., additional, Benson, A., additional, Kahloon, A., additional, Soons, E., additional, Hazzan, R., additional, Landsman, M., additional, Lebwohl, B., additional, Lewis, S., additional, Sivanathan, V., additional, Ngamruengphong, S., additional, Jacob, H., additional, and Siersema, P., additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results